DeutschNewstral
Article
Haaretz on 2015-04-27 20:37
Mylan says Teva offer too low and stock 'unacceptable'
Related news
Mylan Rejects $40 Billion Teva Takeover Offer, Calls Stock 'Low-Quality'Forbes
Mylan says Teva offer too low and stock ‘unacceptable’The Globe and Mail
Teva offers to buy Mylan in $40B cash and stockThe Salt Lake Tribune
Teva offers to buy Mylan in $40.1B cash-and-stock dealneworleanscitybusiness.com
Teva offers to buy Mylan in $40 billion dealtimesofisrael.com
Mylan rejects Teva Pharmaceutical's takeover bidpost-gazette.com- HTeva Shares Up on Mylan-Pfizer Mergerhamodia.com
- Teva Hopes $40 Billion Mylan Deal Will Fuel Stock ReboundForbes
Teva stock surges on Allergan dealbizjournals.com
Teva offers to buy Mylan for $40.1Bobserver-reporter.com- Report: Teva getting ready to up its offer for Mylanbizjournals.com
- Mylan skeptical of rumored Teva bid; hasn’t received offerobserver-reporter.com
- Teva makes unsolicited $82-a-share offer for Mylanbizjournals.com
Teva accuses Mylan of ‘desperate attempt’ to suppress bidtriblive.com- Teva makes $40 billion offer to buy U.S. drug maker MylanHaaretz
- Teva Pharmaceutical says its offer to buy Mylan is 'strong and serious'post-gazette.com
- Mylan again boosts offer for drugmaker Perrigotriblive.com
- With Teva out of the way, stage set for Mylan to make new go at Perrigobizjournals.com
- Teva pursuit of drugmaker Mylan shares affords chance to sway shareholderstriblive.com
- Mylan chief: Acquisition by Teva not feasibleHaaretz